Journal Watch · eLife · 2026

Isolation of small extracellular vesicles from small volumes of blood plasma using size exclusion chromatography and density gradient ultracentrifugation.

In conclusion, the optimized SEC-DGUC protocol is efficient, highly reproducible, and well suited for isolating high-purity sEVs from small blood volumes.

Kong F, Upadya M, Wong ASW et al.eLife3 min readPharma relevance 40/100

DOI: 10.7554/elife.92796PMID: 42170952Study type: research study

TL;DR

In conclusion, the optimized SEC-DGUC protocol is efficient, highly reproducible, and well suited for isolating high-purity sEVs from small blood volumes.

Key findings

  • We further characterized the isolated sEVs obtained from the SEC-DGUC protocol using flow cytometry and mass spectrometry to assess their quality and purity.
  • In conclusion, the optimized SEC-DGUC protocol is efficient, highly reproducible, and well suited for isolating high-purity sEVs from small blood volumes.

What they did

In this study, we aimed to determine the optimal combination and sequence of SEC and DGUC for isolating sEVs from small plasma volumes, in order to enhance both the efficiency and purity of the resulting isolates. To achieve this, we compared sEV isolation using two combinations: SEC-DGUC and DGUC-SEC, from unit volumes of 500 μL plasma. Both protocols successfully isolated high-purity sEVs; however, the SEC-DGUC combination yielded higher sEV protein and RNA content.

Full abstract (original)

Background: Small extracellular vesicles (sEVs) are heterogeneous biological vesicles released by cells under both physiological and pathological conditions. Due to their potential as valuable diagnostic and prognostic biomarkers in human blood, there is a pressing need to develop effective methods for isolating high-purity sEVs from the complex milieu of blood plasma, which contains abundant plasma proteins and lipoproteins. Size exclusion chromatography (SEC) and density gradient ultracentrifugation (DGUC) are two commonly employed isolation techniques that have shown promise in addressing this challenge.

What they did: In this study, we aimed to determine the optimal combination and sequence of SEC and DGUC for isolating sEVs from small plasma volumes, in order to enhance both the efficiency and purity of the resulting isolates. To achieve this, we compared sEV isolation using two combinations: SEC-DGUC and DGUC-SEC, from unit volumes of 500 μL plasma. Both protocols successfully isolated high-purity sEVs; however, the SEC-DGUC combination yielded higher sEV protein and RNA content.

Results & conclusions: We further characterized the isolated sEVs obtained from the SEC-DGUC protocol using flow cytometry and mass spectrometry to assess their quality and purity. In conclusion, the optimized SEC-DGUC protocol is efficient, highly reproducible, and well suited for isolating high-purity sEVs from small blood volumes.

Abstract © the authors / eLife (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.7554/elife.92796 · PubMed 42170952.

Why it matters for pharma & biotech

  • Relevant to General & Medicine teams tracking eLife for new targets, mechanisms and biomarkers.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this eLife study find?

In conclusion, the optimized SEC-DGUC protocol is efficient, highly reproducible, and well suited for isolating high-purity sEVs from small blood volumes.

What type of study is this?

It is a research study, published in eLife in 2026. In this study, we aimed to determine the optimal combination and sequence of SEC and DGUC for isolating sEVs from small plasma volumes, in order to enhance both the efficiency and purity of the resulting isolates.

Where can I read the original paper?

The original is at the publisher via DOI 10.7554/elife.92796. PubMed ID: 42170952. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Kong F, Upadya M, Wong ASW et al.. Isolation of small extracellular vesicles from small volumes of blood plasma using size exclusion chromatography and density gradient ultracentrifugation.. eLife (2026). DOI: 10.7554/elife.92796.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/isolation-of-small-extracellular-vesicles-from-small-volumes-of-blood-pl-e92796/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides